Summaries of Product Characteristics (SPC) for Human medicinal products

The summaries of product characteristics (SPC) contain the information relevant to the use of the medicinal products and of importance to health care professionals. The SPCs are published in Finnish; the use of Finnish key words in the search fields is therefore recommended.

Some of the medicinal products contain a condition relevant to the prescribing of the product and not always found in the SPC. The conditions for prescribing and the products covered by this condition are found in the FimeaWeb search.

The SPCs processed as part of the EU centralised marketing authorisation procedure are published by the European Medicines Agency, EMA. Fimea's service contains links to the documents on medicinal products (EPAR PI) on the EMA website. Drugs belonging to the centralised authorisation procedure can be searched in Fimea's service by using an alphabetical list or by entering the product name or ATC code.

The material being published is not necessarily complete or up-to-date due to the technical quality of files submitted to the Finnish Medicines Agency Fimea or earlier to the National Agency for Medicines and the delays in delivery. For this reason, Fimea cannot guarantee that the document on the Internet fully complies with the summary of product characteristics and package leaflet officially approved by a desicion for a marketing authorisation. Only the hard copies of the SPCs and the PLs, which are in accordance with the marketing authorisation, are conclusive.

Summaries of Product Characteristics 31 - 60 of 250
<  Previous 30    |  1  2  3  4  5  6  7  8  9  |  Next 30   >
Package leaflet	Status for supply	Name of the medicinal product
PL	Resepti	Oftan Dexa 1 mg-g silmävoide SPC 2024-03-14
PL	Resepti	Oftan Dexa 1 mg-ml silmätipat, liuos SPC 2021-12-31
PL	Resepti	Oftan Dexa-Chlora silmätipat, liuos SPC 2021-12-31
PL	Resepti	Oftan Dexa-Chlora silmävoide SPC 2024-3-14
PL	Resepti	Oftan Flurekain 1,25 mg-ml + 3 mg-ml silmätipat, liuos SPC 2022-02-04
PL	Resepti	Oftan Metaoksedrin 100 mg-ml silmätipat, liuos SPC 2021-10-11
PL	Resepti	Oftan Obucain 4 mg-ml silmätipat, liuos SPC 2021-12-22
PL	Itsehoito	OFTAN STARINE 0,5 mg-ml silmätipat, liuos SPC 2021-12-22
PL	Resepti	OFTAN SYKLO 10 mg-ml silmätipat, liuos SPC 2021-12-22
PL	Resepti	OFTAN SYKLO 5 mg-ml silmätipat, liuos SPC 2021-12-22
PL	Resepti	Oftan Timolol 5 mg-ml silmätipat, liuos SPC 2021-10-18
PL	Resepti	Oftan Tropicamid 5 mg-ml silmätipat, liuos SPC 2021-12-22
PL	Resepti	Oftaquix 5 mg-ml silmätipat, liuos, kerta-annospakkaus SPC 2021-08-02
PL	Resepti	Oftaquix 5 mg_ml silmätipat,liuos SPC 2020-10-02
PL	Resepti	Oftastad 50 mikrog-ml silmätipat, liuos SPC 2022-05-09
PL	Resepti	Oftastad comp 50 mikrog-ml + 5 mg-ml silmätipat, liuos SPC 2022-03-23
		European Medicines Agency's website: Ogivri - EMA: EPAR PI Finnish Swedish
		European Medicines Agency's website: Ogluo - EMA: EPAR PI Finnish Swedish
		European Medicines Agency's website: OKEDI - EMA: EPAR PI Finnish Swedish
PL	Itsehoito	Okitask 25 mg rakeet SPC 2023-08-22
PL	Itsehoito	Okitask 25 mg tabletti, kalvopäällysteinen SPC 2023-08-22
PL	Resepti	Olanzapin ABZ-Pharma 2.5mg, 5mg, 7.5mg, 10mg, 15mg, 20mg tabletti SPC 2008-10-17
PL	Resepti	Olanzapin ABZ-Pharma 5mg, 10mg, 15mg, 20mg tabletti, suussa hajoava SPC 2008-10-17
PL	Resepti	Olanzapin CT-Arzneimittel 2.5mg,5mg,7.5mg,10mg,15mg,20mg tabletti SPC 2008-10-17
PL	Resepti	Olanzapin CT-Arzneimittel 5mg,7.5mg,10mg,15mg,20mg tabletti,suussa hajoava SPC 2008-10-17
PL	Resepti	Olanzapin Lilly Velotab 10 mg suussa hajoava tabletti SPC 2011-01-17
PL	Resepti	Olanzapin Lilly Velotab 15 mg suussa hajoava tabletti SPC 2011-01-17
PL	Resepti	Olanzapin LIlly Velotab 20 mg suussa hajoava tabletti SPC 2011-01-17
PL	Resepti	Olanzapin Orion 2.5 mg, 5 mg, 7.5 mg, 10 mg, 15 mg, 20 mg tabletti SPC 2023-11-21
PL	Resepti	Olanzapin Orion 5 mg, 10 mg, 15 mg, 20 mg tabletti, suussa hajoava SPC 2020-09-09
<  Previous 30    |  1  2  3  4  5  6  7  8  9  |  Next 30   >